GAL-001: Adaptive Phase II in Refractory Melanoma · Phase II
Mount Halifax Oncology Center · Dr. A. Reyes
consented 2026-04-30
AEs
1
Serious
0
Dropout signal
+0.0
☾ Luna — Maya Okonkwo
granted
💬 4
⚠ 0 escalations
mood ø 4.0
meds 86%
📅 Cycle 5 infusion — NXC-101 on 2026-08-20
Adverse events
mild
assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2022-04-24 (study day 19); relationship: not assessed
Data queries
weight_kg
auto_resolved
Missing value at Visit 3; source document shows 72 kg.